美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物科技

59.52

+1.021.75%

涨家数：420

跌家数：115

平家数：5

市盈率：- -

高：59.54

开：58.50

低：58.50

收：58.50

成交量：7.53亿

成交额：104.21亿

市值：1.55万亿

流通市值：1.39万亿

数据加载中...

明晟公司MSCI北欧国家指数涨0.1%报340.56点。在10个板块中北欧医疗保健板块领跑。生物技术公司Genmab A

伯恩斯坦下调安进目标价至335美元

癌症早筛公司Grail（GRAL）更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合

癌症早筛公司Grail更新2025年现金消耗指引

环球市场播报

BUZZ-伯恩斯坦以MariTide风险为由下调安进公司的交易预测值

BUZZ-血癌细胞疗法获得早期数据后，免疫生物公司业绩上升

Immatics N.V.盘中异动大幅下跌11.84%报5.66美元

XOMA Royalty Corp 报告截至 6 月 30 日的季度业绩 - 收益摘要

BUZZ-一代生物因战略审查和大幅裁员而大幅上涨

BUZZ-ARS Pharma 第二季度收入超出预期，股价上涨

电气石生物公司（Tourmaline Bio Inc）报告截至 6 月 30 日的季度业绩 - 收益摘要

BUZZ-券商观点：美国食品和药物管理局（FDA）批准Insmed的肺病治疗药物是 "一股清新的空气

以太坊上触4700美元之际美股“以太坊储备概念”集体上扬ATNF涨超50%SBET涨超3%“以太币第一财库”BMNR涨近

亚盛医药-B08月13日获主力加仓1320.6万元

百济神州(688235.SH)发布投资者关系活动记录表公告称公司近期将完成多项里程碑事件。到2026年底公司预计索托克拉

研报掘金丨信达证券：药石科技后端CDMO业务增长亮眼，盈利能力存在较大提升空间

Summit Therapeutics Inc.8月12日成交额为1.66亿美元

深度评论网批评西朱瑞特项目的多个高价值Mreo区域

澳洲财经见闻

奥洛兹美医疗8月12日成交额为1.51亿美元

精密科学8月12日成交额为1.46亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4139/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4139","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4139\",,,,,undefined,":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":59.526703,"timestamp":1755112649238,"preClose":58.503128,"halted":0,"volume":753073184,"delay":0,"changeRate":0.017496,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":1.023575,"latestTime":"08-13 15:17:29 EDT","open":58.503036,"high":59.541534,"low":58.502995,"amount":10421372880.589685,"amplitude":0.017752,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1755115200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.846338,"peRate":-112.457337,"turnoverRate":0.024526,"increases":419,"decrements":114,"flats":6,"marketCap":1552310306864.5,"floatMarketCap":1386026885020.5684},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4139\",,,,,undefined,":{"symbol":"BK4139","high":59.541534,"amplitude":0.017752,"preClose":58.503128,"low":58.502995,"pbRate":"5.846338","latestPrice":59.523983,"volume":753156377,"delay":0,"open":58.503036,"prevYearClose":54.762566,"prevWeekClose":57.9806,"prevMonthClose":57.7408,"prevQuarterClose":55.2146,"fiveDayClose":57.6165,"twentyDayClose":57.6704,"sixtyDayClose":53.4543,"secType":"PLATE","market":"US","turnoverRate":0.024527,"peRate":-112.457337,"marketCap":1552273975842.5,"floatMarketCap":1386016860377.5684,"timestamp":1755112653318,"nameCN":"生物科技"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4139\",,,,undefined,":{"bkCode":"BK4139","up":420,"down":115,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4139\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559598801","title":"明晟公司MSCI北欧国家指数涨0.1%报340.56点。在10个板块中北欧医疗保健板块领跑。生物技术公司Genmab A","url":"https://stock-news.laohu8.com/highlight/detail?id=2559598801","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559598801?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 23:37","pubTimestamp":1755099475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4112","LU2265009873.SGD","LU0109391861.USD","LU2095319765.USD","LU2210150020.SGD","GNMSF","LU0175139822.USD","LU0289739343.SGD","LU0289960550.SGD","LU0511384066.AUD","LU0320765059.SGD","LU0708995401.HKD","LU1267930730.SGD","BK4585","LU0672654240.SGD","LU0289961442.SGD","MSCI","BK4139","LU1804176565.USD","LU2210149790.SGD","BK4588","GMAB"],"gpt_icon":0},{"id":"2559398827","title":"伯恩斯坦下调安进目标价至335美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559398827","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559398827?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 23:25","pubTimestamp":1755098750,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2242652126.USD","LU0868494617.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4534","LU0320765992.SGD","LU1571399168.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4585","LU0889565916.HKD","BK4599","LU0122379950.USD","LU1061106388.HKD","LU0109394709.USD","BK4533","BK4566","LU2112291526.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU0058720904.USD","AMGN","IE00B2B36J28.USD","IE0009355771.USD","LU1023059063.AUD","LU2089984988.USD","BK4139","SG9999001440.SGD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4588","BK4581","LU1057294990.SGD"],"gpt_icon":0},{"id":"2559600794","title":"癌症早筛公司Grail（GRAL）更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559600794?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 22:30","pubTimestamp":1755095402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2559998664","title":"癌症早筛公司Grail更新2025年现金消耗指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2559998664","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559998664?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 22:29","pubTimestamp":1755095340,"startTime":"0","endTime":"0","summary":"癌症早筛公司Grail（GRAL）更新2025年现金消耗指引至3.1亿美元，主要由于其Galleri检测产品采用率提升及合作伙伴关系扩展。得益于检测订单增长，该公司报告净亏损同比改善93%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-13/doc-infkwfyp3810947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2559600214","title":"BUZZ-伯恩斯坦以MariTide风险为由下调安进公司的交易预测值","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600214","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559600214?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 22:24","pubTimestamp":1755095040,"startTime":"0","endTime":"0","summary":"** 经纪公司称，新目标剂量和进入后期研究的剂量调整会带来额外风险** 经纪公司称，下调目标价反映出 \"对 MariTide 达到最佳目标产品形象的可能性信心不足\"。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U5110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","BK4533","IE00BFTCPJ56.SGD","LU0122379950.USD","BK4534","LU1983299246.USD","BK4139","LU2242646821.SGD","LU0109394709.USD","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","LU2089984988.USD","LU1023059063.AUD","IE0002141913.USD","LU1061106388.HKD","LU2468319806.SGD","LU0289739699.SGD","LU0868494617.USD","IE00B2B36J28.USD","BK4585","BK4581","LU2242652126.USD","SG9999001440.SGD","IE00B4R5TH58.HKD","BK4599","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4566","LU0889565916.HKD","AMGN"],"gpt_icon":0},{"id":"2559760086","title":"BUZZ-血癌细胞疗法获得早期数据后，免疫生物公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2559760086","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559760086?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 21:48","pubTimestamp":1755092894,"startTime":"0","endTime":"0","summary":"BUZZ-血癌细胞疗法获得早期数据后，免疫生物公司业绩上升8月13日 - ** 生物技术公司ImmunityBio IBRX.O股价上涨4.5%，至2.58美元** 公司称其实验性细胞疗法在一项早期研究中帮助两名患者消除了一种血癌的所有症状** 这种名为CD19 CAR-NK的疗法正在开发中，用于治疗Waldenstrom巨球蛋白血症--一种影响白细胞的罕见、生长缓慢的癌症。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U50YX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2559985879","title":"Immatics N.V.盘中异动 大幅下跌11.84%报5.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559985879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559985879?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 21:34","pubTimestamp":1755092042,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日21时34分，Immatics N.V.股票出现波动，股价急速跳水11.84%。截至发稿，该股报5.66美元/股，成交量7.8953万股，换手率0.06%，振幅9.74%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.44%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，从事用于治疗癌症患者的 T 细胞重定向免疫疗法的研发。该公司通过与第三方制药和生物技术公司签订战略合作协议来赚取收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813213402a486789b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813213402a486789b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2559604252","title":"XOMA Royalty Corp 报告截至 6 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2559604252","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559604252?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 20:18","pubTimestamp":1755087529,"startTime":"0","endTime":"0","summary":"XOMA Royalty Corp 报告截至 6 月 30 日的季度业绩 - 收益摘要XOMA Royalty Corp XOMA.OQ公布的截至6月30日的季度调整后每股收益为44美分，低于去年同期的每股收益84美分。四位分析师对该季度的平均预期是每股亏损 22 美分。XOMA Royalty Corp公布的本季度每股收益为44美分。公司报告的季度净收入为 552 万美元。XOMA Royalty Corp 的股价本季度上涨了 12.9%，今年迄今为止上涨了 8.3%。华尔街对 XOMA Royalty Corp 的 12 个月目标价中位数为 55.00 美元，比上次收盘价 28.46 美元高出约 48.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4T3U50T8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2559017626","title":"BUZZ-一代生物因战略审查和大幅裁员而大幅上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2559017626","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559017626?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 19:52","pubTimestamp":1755085932,"startTime":"0","endTime":"0","summary":"BUZZ-一代生物因战略审查和大幅裁员而大幅上涨8月13日 - ** 药物开发商Generation Bio GBIO.O股价盘前上涨30%至5.28美元** 周二晚些时候，该公司表示正在探索战略替代方案 ，包括出售、合并或资产交易。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U50S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4584","GBIO"],"gpt_icon":0},{"id":"2559271601","title":"BUZZ-ARS Pharma 第二季度收入超出预期，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2559271601","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559271601?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 19:48","pubTimestamp":1755085680,"startTime":"0","endTime":"0","summary":"** 预计奈飞将于 2026 年上半年在中国获得监管部门批准** 截至 6 月 30 日，ARS 制药公司拥有现金、现金等价物和短期投资 2.401 亿美元。** 截至上次收盘，股价累计上涨 57.9 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U50RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2559060160","title":"电气石生物公司（Tourmaline Bio Inc）报告截至 6 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2559060160","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559060160?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 19:33","pubTimestamp":1755084831,"startTime":"0","endTime":"0","summary":"电气石生物公司报告截至 6 月 30 日的季度业绩 - 收益摘要Tourmaline Bio Inc TRML.OQ报告了截至6月30日的季度调整后每股亏损90美分，低于去年同期的每股收益-68美分。10位分析师对该季度的平均预期是每股亏损94美分。Tourmaline Bio Inc 报告的季度每股收益为亏损 90 美分。该公司当季亏损 2,309 万美元。本季度，Tourmaline Bio Inc 的股价上涨了 34.3%，今年迄今为止上涨了 5.9%。华尔街对电气石生物公司12 个月目标价的中位数为 56.50 美元，比上一交易日的收盘价 21.48 美元高出约 62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4T3U50QS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2559609493","title":"BUZZ-券商观点：美国食品和药物管理局（FDA）批准Insmed的肺病治疗药物是 \"一股清新的空气","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609493","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559609493?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 19:11","pubTimestamp":1755083474,"startTime":"0","endTime":"0","summary":"8月13日 - ** 美国食品和药物管理局周二批准了  Insmed公司INSM.O的口服药物Brinsupri，作为治疗非囊性纤维化支气管扩张症的第一种药物，支气管扩张症是一种以气道受损、持续咳嗽和粘液分泌过多为特征的慢性肺病。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4T3U50PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","INSM","LU0889565916.HKD","BK4139","LU0053671581.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2559605217","title":"以太坊上触4700美元之际美股“以太坊储备概念”集体上扬ATNF涨超50%SBET涨超3%“以太币第一财库”BMNR涨近","url":"https://stock-news.laohu8.com/highlight/detail?id=2559605217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559605217?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 18:07","pubTimestamp":1755079670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ETHA","IBIT","ETHV","09179","BK4139","BK4147","BK4585","09046","BK4601","CETH","SBET","BK4588","BMNR","ETH.USD.CC","BK1611","BK4594","ATNF","FETH","ETH","03046","ETH.USD.HKCC","LDO.USD.HKCC","BK4023","OP.USD.HKCC","QETH","ETHE","03009","ETHmain","EZET","09009","ETHW","BK4150","03179"],"gpt_icon":0},{"id":"2559834599","title":"亚盛医药-B08月13日获主力加仓1320.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559834599","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559834599?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 16:15","pubTimestamp":1755072937,"startTime":"0","endTime":"0","summary":"08月13日, 亚盛医药-B股价涨3.45%，报收81.00元，成交金额2.4亿元，换手率0.81%，振幅4.28%，量比0.60。亚盛医药-B今日主力资金净流入1320.6万元，上一交易日主力净流入1520.2万元。该股近5个交易日下跌3.11%，主力资金累计净流出1928.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5246.8万元，其中净流出天数为12日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813170129a485ff36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813170129a485ff36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2559302670","title":"百济神州(688235.SH)发布投资者关系活动记录表公告称公司近期将完成多项里程碑事件。到2026年底公司预计索托克拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2559302670","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559302670?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 16:01","pubTimestamp":1755072062,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2328871848.SGD","BK4139","LU1969619763.USD","BK1588","BK4526","688235","BK1500","LU0307460666.USD","BK1583","BK0239","LU0588546209.SGD","BK1161","ONC","06160","BK4585"],"gpt_icon":0},{"id":"2559867771","title":"研报掘金丨信达证券：药石科技后端CDMO业务增长亮眼，盈利能力存在较大提升空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2559867771","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559867771?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 15:44","pubTimestamp":1755071072,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300725","BK4080","601059","BK4231","CDMO","BK0229","BK0276","BK4139","ADC"],"gpt_icon":0},{"id":"2559098696","title":"Summit Therapeutics Inc.8月12日成交额为1.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559098696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559098696?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 14:46","pubTimestamp":1755067599,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，Summit Therapeutics Inc.成交额为1.66亿美元，成交额较昨日增加206.15%，当日成交量为650.57万股。Summit Therapeutics Inc.于2025年8月12日跌9.08%，报25.69美元，该股过去5个交易日跌11.83%，年初至今涨43.89%，过去60日涨11.24%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-12|1.66亿|206.15%|650.57万|#|2025-08-11|5429.00万|-1.65%|190.17万|#|2025-08-08|5519.87万|15.21%|192.31万|#|2025-08-07|4791.13万|-24.99%|171.86万|#|2025-08-06|6387.04万|-44.62%|223.96万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813144641a485b933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813144641a485b933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2559679088","title":"深度评论网批评西朱瑞特项目的多个高价值Mreo区域","url":"https://stock-news.laohu8.com/highlight/detail?id=2559679088","media":"澳洲财经见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559679088?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 13:10","pubTimestamp":1755061804,"startTime":"0","endTime":"0","summary":"批评（ASX：CRI） 在对其在西澳大利亚州北部的木星项目的进一步审查中，已经确定了多个高价值磁铁稀土（MREO）区域。…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e6%b7%b1%e5%ba%a6%e8%af%84%e8%ae%ba%e7%bd%91%e6%89%b9%e8%af%84%e8%a5%bf%e6%9c%b1%e7%91%9e%e7%89%b9%e9%a1%b9%e7%9b%ae%e7%9a%84%e5%a4%9a%e4%b8%aa%e9%ab%98%e4%bb%b7%e5%80%bcmreo%e5%8c%ba%e5%9f%9f/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2559603823","title":"奥洛兹美医疗8月12日成交额为1.51亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559603823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559603823?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 10:48","pubTimestamp":1755053302,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，奥洛兹美医疗成交额为1.51亿美元，成交额较昨日增加12.18%，当日成交量为237.92万股。奥洛兹美医疗于2025年8月12日涨1.83%，报64.04美元，该股过去5个交易日涨5.31%，年初至今涨33.95%，过去60日涨30.83%。该公司寻求开发以改变肿瘤的人类酶为重点的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813104828a4854951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813104828a4854951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HALO","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2559298374","title":"精密科学8月12日成交额为1.46亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559298374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559298374?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 10:18","pubTimestamp":1755051514,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，精密科学成交额为1.46亿美元，成交额较昨日减少20.77%，当日成交量为350.93万股。精密科学于2025年8月12日涨2.03%，报41.74美元，该股过去5个交易日跌11.87%，年初至今跌25.72%，过去60日跌25.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-12|1.46亿|-20.77%|350.93万|#|2025-08-11|1.84亿|-29.43%|450.15万|#|2025-08-08|2.61亿|-65.09%|621.28万|#|2025-08-07|7.47亿|277.12%|1786.31万|#|2025-08-06|1.98亿|76.00%|423.52万|精密科学总部位于美国威斯康辛州麦迪逊市，在美国和国际范围内提供癌症筛查和诊断测试产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813101835a6e2c886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813101835a6e2c886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","LU0266013472.USD","LU2324357040.USD","EXAS","BK4139","BK4588","LU1861559042.SGD","BK4585","LU1861558580.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":85,"pageCount":1,"totalSize":1693,"code":"91000000","status":"200"}]}}